Report says COVID-19 patients respond to Gilead's remdesivir, shares surge

A University of Chicago hospital participating in a study of the antiviral medication said it is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, according to medical news website STAT https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment. Gilead, in an emailed statement, said “the totality of the data need to be analyzed in order to draw any conclusions from the trial.” UChicago Medicine, also in an email, said “partial data from an ongoing clinical trial is by definition incomplete and should never be used to draw conclusions.” …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.